Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-24 @ 5:25 PM
NCT ID:
NCT00460850
Eligibility Criteria:
Inclusion Criteria:
* adult patients, 18-65 years of age;
* HBeAg negative chronic hepatitis B;
* treated with lamivudine for \>=6 months;
* demonstrated lamivudine resistance;
* compensated liver disease.
Exclusion Criteria:
* severe hepatic dysfunction;
* previous treatment with antivirals other than lamivudine;
* immunosuppressant treatment in past 6 months;
* co-infection with hepatitis A, C, or D virus or human immunodeficiency virus;
* medical condition associated with chronic liver disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00460850
Study Brief:
Protocol Section:
NCT00460850